UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ALLOVIR INC ownership

ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 83 filers reported holding ALLOVIR INC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ALLOVIR INC
ValueSharesWeighting
Q3 2023$50,884
-45.4%
23,6670.0%0.00%
Q2 2023$93,2480.0%23,6670.0%0.00%
Q1 2023$93,248
-99.9%
23,667
+63.9%
0.00%
Q3 2022$113,947,000
-3.8%
14,442
-52.5%
0.00%
Q2 2022$118,475,000
-42.2%
30,3780.0%0.00%
Q1 2022$205,051,000
-47.8%
30,3780.0%0.00%
Q4 2021$393,090,000
-42.2%
30,378
+12.0%
0.00%
Q3 2021$679,528,000
+157.7%
27,116
+103.0%
0.00%
Q2 2021$263,648,00013,3560.00%
Other shareholders
ALLOVIR INC shareholders Q4 2023
NameSharesValueWeighting ↓
Artal Group S.A. 2,323,371$63,893,0001.55%
Redmile Group, LLC 2,333,390$64,168,0001.18%
Woodline Partners LP 1,191,014$32,753,0001.07%
EcoR1 Capital, LLC 447,012$12,293,0000.88%
Samsara BioCapital, LLC 91,057$2,504,0000.70%
SECTORAL ASSET MANAGEMENT INC 277,795$7,639,0000.66%
CNA FINANCIAL CORP 10,745$295,0000.11%
Marshall Wace North America L.P. 580,880$15,974,0000.10%
MIRABELLA FINANCIAL SERVICES LLP 16,791$462,0000.06%
Alkeon Capital Management 1,097,000$30,167,0000.06%
View complete list of ALLOVIR INC shareholders